Published in Health Business Week, December 22nd, 2006
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Threshold Pharmaceuticals.
Report 1: Threshold Pharmaceuticals, Inc. (THLD), announced that Michael Ostrach has resigned as chief operating officer, general counsel and chief financial officer, effective October 27, 2006.
On an interim basis, Ostrach's financial management responsibilities will be assumed by Cathleen Davis, vice president, finance and controller.
The company continues to anticipate the following clinical milestones in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.